Patent Granted on Long-Acting Drug for Multiple Sclerosis
The conjugates covered by this patent could enable less frequent and better tolerated dosing of one of the most widely used treatments worldwide for relapsing-remitting multiple sclerosis,...
View ArticlePfizer Focuses Recent Patent Activity on Antibacterial Agents
Patent applications recently published by the U.S. Patent and Trademark Office show that Pfizer’s recent development goals have focused on a broad spectrum of diseases and disorders... Treatments for a...
View Article
More Pages to Explore .....
